Open AccessROS1 in Squamous Non-Small Cell Lung Cancer—Combined Immunotherapy (PD1/CTLA4) or Targeted Therapy?
Author(s) -
Alexander Yakobson,
Tal Mor,
Dina Levitas,
Laila C. Roisman,
Daniel Levin,
Wafeek Alguayn,
Sara Morgenstern,
Keren Rouvinov,
Nir Peled,
Waleed Kian
Publication year - 2020
Publication title -
journal of cancer therapy
Language(s) - English
Resource type - Journals
eISSN - 2151-1942
pISSN - 2151-1934
DOI - 10.4236/jct.2020.116031
Subject(s) - crizotinib , ros1 , medicine , adenocarcinoma , lung cancer , cancer research , oncology , immunotherapy , cancer , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom